Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Advaxis Inc (ADXS)

Advaxis Inc (ADXS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 59,712
  • Shares Outstanding, K 145,638
  • Annual Sales, $ 250 K
  • Annual Income, $ -26,470 K
  • 60-Month Beta 2.40
  • Price/Sales 237.17
  • Price/Cash Flow N/A
  • Price/Book 1.32
Trade ADXS with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.26
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 09/09/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3960 +3.54%
on 07/27/21
0.7100 -42.25%
on 07/06/21
-0.0537 (-11.58%)
since 06/30/21
3-Month
0.3668 +11.78%
on 05/13/21
0.7597 -46.03%
on 05/19/21
-0.0790 (-16.16%)
since 04/30/21
52-Week
0.2639 +55.36%
on 11/24/20
1.5700 -73.89%
on 02/17/21
-0.1844 (-31.02%)
since 07/30/20

Most Recent Stories

More News
INVESTIGATION: Halper Sadeh LLP Investigates LONE, KIN, GRA, ADXS; Shareholders are Encouraged to Contact the Firm

NEW YORK, NY / ACCESSWIRE / July 22, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

LONE : 9.8500 (+9.44%)
KIN : 9.12 (+0.44%)
GRA : 69.60 (+0.06%)
ADXS : 0.4100 (-0.49%)
Report 2021, Cervical Cancer Screening Market | Global Size, Share, Growth, Trends, Revenue Analysis, Competitive Landscape, Forecast 2028

The global cervical cancer screening market size is expected to gain momentum owing to the increasing prevalence of cancer during the forecast period. This information is published by Fortune Business...

ADXS : 0.4100 (-0.49%)
MRK : 76.87 (-0.08%)
PFE : 42.81 (+0.05%)
DGX : 141.80 (+0.40%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds ICON, ADXS, QADA; QADB, and SNR Shareholders About Its Ongoing Investigations

/PRNewswire/ --

QADA : 86.75 (-0.07%)
QADB : 86.05 (-0.12%)
ICON : 3.15 (unch)
ADXS : 0.4100 (-0.49%)
SNR : 9.22 (+0.22%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates UFS, HBMD, ICBK, ADXS; Shareholders are Encouraged to Contact the Firm

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

UFS : 54.91 (-0.07%)
HBMD : 19.70 (-0.86%)
ICBK : 34.69 (+0.23%)
ADXS : 0.4100 (-0.49%)
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Advaxis, Inc. - ADXS

/PRNewswire/-- , founder and managing partner at , a national securities firm rated in the 2018-2020 ISS Securities Class Action Services Report and headquartered at the Empire State Building in , is...

ADXS : 0.4100 (-0.49%)
Advaxis Announces Initiation of Phase 1 Clinical Trial of ADXS-504 for the Treatment of Early Prostate Cancer

Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products, today announced the initiation of its Phase 1 clinical study...

ADXS : 0.4100 (-0.49%)
Advaxis to Present at the Non-Small Cell Lung Cancer Drug Development Summit

Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products, today announced that Andres Gutierrez, M.D., Executive Vice...

ADXS : 0.4100 (-0.49%)
INVESTIGATION ALERT: Halper Sadeh LLP Investigates STFC, HBMD, ICBK, ADXS, FOE; Shareholders are Encouraged to Contact the Firm

/PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

STFC : 50.00 (-0.18%)
HBMD : 19.70 (-0.86%)
ICBK : 34.69 (+0.23%)
ADXS : 0.4100 (-0.49%)
FOE : 20.80 (-0.67%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds UFS, ADXS, QADA; QADB, and SNR Shareholders About Its Ongoing Investigations

/PRNewswire/ --

QADA : 86.75 (-0.07%)
QADB : 86.05 (-0.12%)
UFS : 54.91 (-0.07%)
ADXS : 0.4100 (-0.49%)
SNR : 9.22 (+0.22%)
INVESTIGATION ALERT: Halper Sadeh LLP Investigates JAX, STMP, IKNX, ADXS; Shareholders are Encouraged to Contact the Firm

NEW YORK, NY / ACCESSWIRE / July 11, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

JAX : 13.81 (-0.29%)
STMP : 326.76 (+0.07%)
IKNX : 21.77 (-0.91%)
ADXS : 0.4100 (-0.49%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Advaxis, Inc. is a development stage biotechnology company focused on developing safe and effective cancer vaccines that utilize multiple mechanisms of immunity. The Company is developing a live Listeria vaccine technology under license from the University of Pennsylvania which secretes a protein sequence...

See More

Key Turning Points

3rd Resistance Point 0.4373
2nd Resistance Point 0.4319
1st Resistance Point 0.4209
Last Price 0.4100
1st Support Level 0.4045
2nd Support Level 0.3991
3rd Support Level 0.3881

See More

52-Week High 1.5700
Fibonacci 61.8% 1.0711
Fibonacci 50% 0.9170
Fibonacci 38.2% 0.7628
Last Price 0.4100
52-Week Low 0.2639

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar